Cubol, Emelda D.
HRN: 28-68-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/09/2026
03/15/2026
IV
4.5gm
Q8
Urosepsis And DM Foot Right
Checking Initial Appropriateness
03/09/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/09/2026
03/15/2026
IV
600mg
Q8
Urosepsis And DM Foot Right
Checking Initial Appropriateness
03/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2026
03/26/2026
IV
4.5
Q6H
UROSEPSIS, SEPSIS
Checking Initial Appropriateness